Jeremy Rudnick, M.d

This study was designed to test a treatment using a patient's own immune cells (T cells) to fight recurrent glioblastoma, an aggressive brain cancer. The cells were to be activated in a lab to target cancer stem cells. However, the trial was withdrawn before any participants were…